"ID","7e-04","Description","8e-04","9e-04","0.001","0.0011","0.0012","0.0013","0.0014","0.0015","0.0016","0.0017","0.0018","0.0019","0.002","0.0021","0.0022","0.0023","0.0024","0.0025","0.0026","0.0027","0.0028","0.0029","0.003","0.0031","0.0032","0.0033","0.0034","0.0035","0.0036","0.0037","0.0038","0.0039","0.004"
"R-HSA-1852241",0.100491435868298,"Organelle biogenesis and maintenance",0.084310167319756,0.0317189881309953,0.0850704897844556,0.0652933536129039,0.0860817807263635,0.0447058241282237,0.0769133184665964,0.269647862864669,0.249903819383786,0.15348108224207,0.225546313538332,0.070810557308879,0.185806537196551,0.152173162161129,0.119069604597036,0.102038042449496,0.0392920714277303,0.17029419519474,0.17029419519474,0.0837573091354946,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-1592230",0.100491435868298,"Mitochondrial biogenesis",0.0529503195555284,0.00613965982961247,0.00890665644996301,0.003282990590752,0.00748867148792119,0.00219956977054924,0.00353794808929944,0.178807407442416,0.13898452853858,0.136958270860816,0.0711884918025722,0.0265154188574314,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.0988281641216156,0.0988281641216156,0.0479922701872091,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-373760",0.100491435868298,"L1CAM interactions",0.499220521760078,0.698367370736984,0.7293124826145,0.877816783476576,0.722139652707051,0.580230929094453,0.497199393992069,0.511758497902849,0.464753219189882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168138",0.100491435868298,"Toll Like Receptor 9 (TLR9) Cascade",0.550061853461842,0.582540769255921,0.501338948920119,0.230639332694732,0.256082240270674,0.143134620311818,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-187687",0.100491435868298,"Signalling to ERKs",0.458414649981067,0.261593154324529,0.104772239453556,0.0497817684364846,0.122735027801304,0.0732529710878121,0.142507981222421,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9612973",0.100491435868298,"Autophagy",0.063587506860143,0.0426092151653893,0.0850704897844556,0.133984827123312,0.208296795589844,0.121261552834095,0.109383794054803,0.162418137675607,0.125991744159154,0.160181642244384,0.238749587600447,0.0887271241693921,0.253473870769759,0.231443527400156,0.196478933589034,0.175759600447619,0.127159055329602,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-168898",0.100491435868298,"Toll-like Receptor Cascades",0.499220521760078,0.661443774851485,0.55054371226615,0.305812138090408,0.506332724759233,0.293251169091305,0.19603737685714,0.471873591700058,0.420556382952476,0.275689107778181,0.314935921447011,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.149100913689124,0.0645101777615808,0.207121691417064,0.207121691417064,0.162681207736912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6804756",0.100491435868298,"Regulation of TP53 Activity through Phosphorylation",0.0618555717742676,0.00613965982961247,0.00890665644996301,0.00835506187897522,0.00990569724450506,0.00247849265717256,0.00137148474279674,0.0305326424702098,0.0183401040810816,0.0905947603208051,0.040329621443948,0.0130479718518276,0.181074940126864,0.137985009042006,0.0939541489107025,0.100064839560178,0.0380077350767509,0.140536967299863,0.140536967299863,0.0687129183153306,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-1632852",0.100491435868298,"Macroautophagy",0.0827463623004043,0.0186958474158211,0.0545921326547328,0.0652933536129039,0.144775061854831,0.0839545334718232,0.0808125936811877,0.132215732228403,0.0821761168736821,0.136958270860816,0.223350391190821,0.070810557308879,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-168181",0.100491435868298,"Toll Like Receptor 7/8 (TLR7/8) Cascade",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-975138",0.100491435868298,"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-975155",0.100491435868298,"MyD88 dependent cascade initiated on endosome",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1445148",0.100491435868298,"Translocation of SLC2A4 (GLUT4) to the plasma membrane",0.458414649981067,0.582540769255921,0.501338948920119,0.305812138090408,0.475461722879649,0.311450781060158,0.250346183663859,0.269647862864669,0.250636891246653,0.16924286757752,0.248428086090244,0.0904598466913261,0.261583695742675,0.234318189819888,0.203030842894229,0.181740282137685,0.127159055329602,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-390466",0.100491435868298,"Chaperonin-mediated protein folding",0.458414649981067,0.582540769255921,0.501338948920119,0.877816783476576,0.73173118323182,0.633049929757761,0.538217978307992,0.552070781985243,0.50893668098751,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-391251",0.100491435868298,"Protein folding",0.458414649981067,0.582540769255921,0.501338948920119,0.877816783476576,0.73173118323182,0.633049929757761,0.538217978307992,0.552070781985243,0.50893668098751,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9619483",0.100491435868298,"Activation of AMPK downstream of NMDARs",0.458414649981067,0.582540769255921,0.501338948920119,0.305812138090408,0.475461722879649,0.311450781060158,0.250346183663859,0.269647862864669,0.250636891246653,0.16924286757752,0.248428086090244,0.0904598466913261,0.261583695742675,0.234318189819888,0.203030842894229,0.181740282137685,0.127159055329602,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-168164",0.100491435868298,"Toll Like Receptor 3 (TLR3) Cascade",0.550061853461842,0.661443774851485,0.501338948920119,0.230639332694732,0.256082240270674,0.143134620311818,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-450282",0.100491435868298,"MAPK targets/ Nuclear events mediated by MAP kinases",0.499220521760078,0.661443774851485,0.47572664288511,0.222361167603081,0.156462721191338,0.0906625997666652,0.0808125936811877,0.253158284005796,0.222356097045719,0.136958270860816,0.225546313538332,0.070810557308879,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168142",0.100491435868298,"Toll Like Receptor 10 (TLR10) Cascade",0.629849855010004,0.661443774851485,0.47572664288511,0.211920508869613,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168176",0.100491435868298,"Toll Like Receptor 5 (TLR5) Cascade",0.629849855010004,0.661443774851485,0.47572664288511,0.211920508869613,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-975871",0.100491435868298,"MyD88 cascade initiated on plasma membrane",0.629849855010004,0.661443774851485,0.47572664288511,0.211920508869613,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-68877",0.100491435868298,"Mitotic Prometaphase",0.535490848519432,0.582540769255921,0.501338948920119,0.82674313581141,0.644881392819249,0.503612405993106,0.424592526770645,0.501351632337259,0.464753219189882,0.503485237639301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2142753",0.100491435868298,"Arachidonic acid metabolism",0.265456650473261,0.236922690839744,0.0850704897844556,0.0339999453479216,0.0613964298345432,0.0732529710878121,0.120640821913982,0.397335382743585,0.374658302751952,0.266406969881309,0.300479001875006,0.293496768958415,0.308347356856433,0.281607466426917,0.244562664541365,0.215700267120055,0.159266751834375,0.18607802994537,0.18607802994537,0.136464787174491,0.0999460008893974,0.0999460008893974,0.0999460008893974,0.0999460008893974,0.0999460008893974,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-166166",0.100491435868298,"MyD88-independent TLR4 cascade ",0.586928083684162,0.677707654447508,0.501338948920119,0.253394477314419,0.265099329858385,0.144950881524306,0.109383794054803,0.265542574285656,0.232275051291594,0.142570701723381,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-937061",0.100491435868298,"TRIF(TICAM1)-mediated TLR4 signaling ",0.586928083684162,0.677707654447508,0.501338948920119,0.253394477314419,0.265099329858385,0.144950881524306,0.109383794054803,0.265542574285656,0.232275051291594,0.142570701723381,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2500257",0.128244224804969,"Resolution of Sister Chromatid Cohesion",0.655355909332317,0.698367370736984,0.84957811135087,0.893976160937466,0.763247949682011,0.64764133270203,0.559895467545273,0.552070781985243,0.50893668098751,0.431918321082083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9018677",0.128244224804969,"Biosynthesis of DHA-derived SPMs",0.458414649981067,0.582540769255921,0.424474794772629,0.208146083129872,0.122735027801304,0.0732529710878121,0.0769133184665964,0.253158284005796,0.222356097045719,0.136958270860816,0.223350391190821,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-166058",0.128244224804969,"MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168179",0.128244224804969,"Toll Like Receptor TLR1:TLR2 Cascade",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168188",0.128244224804969,"Toll Like Receptor TLR6:TLR2 Cascade",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-181438",0.128244224804969,"Toll Like Receptor 2 (TLR2) Cascade",0.655355909332317,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168643",0.128244224804969,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.346600792160584,0.261593154324529,0.104772239453556,0.0477084614992267,0.162156394256631,0.0890457343910424,0.135873357014992,0.449946728369064,0.420556382952476,0.288744679502121,0.413774505911305,0.315644886723145,0.331272749491843,0.29770329734605,0.263178087235182,0.22987836563497,0.17153251854201,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5633007",0.128244224804969,"Regulation of TP53 Activity",0.0865920165149383,0.0136900714289028,0.0481059544747127,0.0233689551386298,0.0228002914169671,0.00500731138408781,0.00180009496200154,0.0305326424702098,0.0183401040810816,0.0905947603208051,0.040329621443948,0.0272050341358733,0.181074940126864,0.147972261504434,0.115526741495597,0.115739636940573,0.0496892426367277,0.176923746180353,0.176923746180353,0.0873772425716472,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-1834949",0.128244224804969,"Cytosolic sensors of pathogen-associated DNA ",0.458414649981067,0.582540769255921,0.439045636446885,0.211920508869613,0.300579068347037,0.195985227995601,0.149014423527745,0.511758497902849,0.464753219189882,0.380891725132946,0.304903302159194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-373752",0.128244224804969,"Netrin-1 signaling",0.458414649981067,0.261593154324529,0.125990292190314,0.0595977613230711,0.133504369011952,0.0732529710878121,0.149014423527745,0.511758497902849,0.464753219189882,0.380891725132946,0.304903302159194,0.194629179672504,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69273",0.128244224804969,"Cyclin A/B1/B2 associated events during G2/M transition",0.458414649981067,0.261593154324529,0.439045636446885,0.485622670468792,0.300579068347037,0.195985227995601,0.149014423527745,0.511758497902849,0.464753219189882,0.380891725132946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9018678",0.128244224804969,"Biosynthesis of specialized proresolving mediators (SPMs)",0.458414649981067,0.582540769255921,0.439045636446885,0.211920508869613,0.133504369011952,0.0732529710878121,0.0769133184665964,0.253158284005796,0.222356097045719,0.136958270860816,0.223350391190821,0.194629179672504,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8978868",0.128244224804969,"Fatty acid metabolism",0.286851383690689,0.20588841048199,0.0692886026723883,0.0233689551386298,0.0775130202826975,0.0732529710878121,0.233592857079637,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.381023498063304,0.372141980164988,0.328419457848676,0.298717623892648,0.281194127905283,0.205057411600876,0.18607802994537,0.18607802994537,0.136464787174491,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-442755",0.128244224804969,"Activation of NMDA receptors and postsynaptic events",0.535490848519432,0.716234566421771,0.776859150812354,0.586260934136991,0.597963531357623,0.378411435353283,0.301546157348275,0.289287809023683,0.250636891246653,0.167481588858438,0.238749587600447,0.070810557308879,0.185806537196551,0.152173162161129,0.119069604597036,0.102038042449496,0.215758548716842,0.187755642851636,0.187755642851636,0.142122627877854,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-198753",0.128244224804969,"ERK/MAPK targets",0.499220521760078,0.661443774851485,0.501338948920119,0.305812138090408,0.256082240270674,0.142706037774409,0.109383794054803,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.181723439387307,0.222778096226677,0.198769789467692,0.168805960418739,0.150805204338451,0.102255492532284,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2162123",0.128244224804969,"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)",0.265456650473261,0.094906897424469,0.0545921326547328,0.0233689551386298,0.0860817807263635,0.142706037774409,0.458865838095113,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-389957",0.128244224804969,"Prefoldin mediated transfer of substrate  to CCT/TriC",0.734615448477808,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8864260",0.128244224804969,"Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors",0.499220521760078,0.661443774851485,0.501338948920119,0.305812138090408,0.256082240270674,0.142706037774409,0.109383794054803,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-187037",0.147448806186677,"Signaling by NTRK1 (TRKA)",0.655355909332317,0.661443774851485,0.501338948920119,0.266863552815001,0.326143860146036,0.195985227995601,0.414213722643382,0.590594998033563,0.563102147706156,0.499263960512326,0.424763272235142,0.323442548879232,0.333011488022036,0.304286972126288,0.265927032548138,0.234083316343261,0.171869924954221,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-448424",0.147448806186677,"Interleukin-17 signaling",0.655355909332317,0.661443774851485,0.501338948920119,0.266863552815001,0.184082236832577,0.0923420759791454,0.0808125936811877,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-450294",0.147448806186677,"MAP kinase activation",0.655355909332317,0.661443774851485,0.501338948920119,0.266863552815001,0.184082236832577,0.0923420759791454,0.0808125936811877,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2565942",0.153556668431468,"Regulation of PLK1 Activity at G2/M Transition",0.655355909332317,0.647546050018658,0.667201985042626,0.844640259550575,0.699965936755003,0.576203072096637,0.497199393992069,0.513865483900248,0.464753219189882,0.388654633469775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-195258",0.163444487299529,"RHO GTPase Effectors",0.535490848519432,0.697963899815732,0.84957811135087,0.844640259550575,0.654583079127524,0.64764133270203,0.545983961000625,0.745079759161294,0.715284021019389,0.650690131647037,0.598161851713903,0.458782445557616,0.426108091621374,0.396175878412976,0.361135757348804,0.340631834616938,0.238048156078449,0.198879259623526,0.198879259623526,0.156148826029096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5620924",0.163444487299529,"Intraflagellar transport",0.766529396366599,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-438064",0.167996940872527,"Post NMDA receptor activation events",0.60989679513105,0.879370430160258,0.84957811135087,0.808356577668708,0.699965936755003,0.576203072096637,0.497199393992069,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.155965567554567,0.373825784243745,0.337746161422817,0.307157813949635,0.288840800094653,0.210416468734895,0.186247587519278,0.186247587519278,0.136634922998475,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-166016",0.169085485816094,"Toll Like Receptor 4 (TLR4) Cascade",0.689809360627865,0.779909412704378,0.59398513992158,0.344615334874813,0.352776774752806,0.195985227995601,0.135873357014992,0.32928412741179,0.292796985516667,0.179371715490493,0.300479001875006,0.178028406762018,0.204443863744332,0.167730909599,0.131474887154477,0.112570680311245,0.0484978995518994,0.187755642851636,0.187755642851636,0.147176065482782,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168928",0.169085485816094,"DDX58/IFIH1-mediated induction of interferon-alpha/beta",0.499220521760078,0.661443774851485,0.47572664288511,0.222361167603081,0.352776774752806,0.23885032042657,0.182118745723653,0.513865483900248,0.464753219189882,0.388896346729287,0.314935921447011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6811434",0.169085485816094,"COPI-dependent Golgi-to-ER retrograde traffic",0.83417462842507,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-983189",0.169085485816094,"Kinesins",0.83417462842507,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3371497",0.169085485816094,"HSP90 chaperone cycle for steroid hormone receptors (SHR)",0.63723013633755,0.879370430160258,0.882324535494606,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-437239",0.169085485816094,"Recycling pathway of L1",0.63723013633755,0.928965172116894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-194315",0.173526357389734,"Signaling by Rho GTPases",0.550061853461842,0.698367370736984,0.84957811135087,0.844640259550575,0.659302591387614,0.656166728880484,0.551474745134908,0.74588709095997,0.716538298549552,0.651690861879102,0.602891680624733,0.458782445557616,0.426535110927922,0.396580363776361,0.361389927539482,0.340742005795088,0.238048156078449,0.198879259623526,0.198879259623526,0.156148826029096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3700989",0.173526357389734,"Transcriptional Regulation by TP53",0.265456650473261,0.0317189881309953,0.0545921326547328,0.0497817684364846,0.0584132629222392,0.0117916816316151,0.00333127367839126,0.132215732228403,0.0821761168736821,0.136958270860816,0.0711884918025722,0.070810557308879,0.181074940126864,0.147972261504434,0.115526741495597,0.150805204338451,0.0985859653122808,0.18607802994537,0.18607802994537,0.136464787174491,0.155059876470869,0.155059876470869,0.155059876470869,0.155059876470869,0.155059876470869,0.0829629629629631,0.0829629629629631,0.0829629629629631,0.0829629629629631,0.0829629629629631,0.0829629629629631,0.0829629629629631,0.0829629629629631
"R-HSA-198725",0.173526357389734,"Nuclear Events (kinase and transcription factor activation)",0.550061853461842,0.677707654447508,0.539477892691927,0.372414764103453,0.256082240270674,0.160750942287644,0.128935346704044,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-389958",0.173526357389734,"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding",0.780709584537213,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-389960",0.173526357389734,"Formation of tubulin folding intermediates by CCT/TriC",0.780709584537213,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-389977",0.173526357389734,"Post-chaperonin tubulin folding pathway",0.780709584537213,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5668599",0.173526357389734,"RHO GTPases Activate NADPH Oxidases",0.550061853461842,0.582540769255921,0.539477892691927,0.372414764103453,0.256082240270674,0.160750942287644,0.128935346704044,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-68875",0.173526357389734,"Mitotic Prophase",0.780709584537213,0.677707654447508,0.539477892691927,0.808356577668708,0.654583079127524,0.542975842601393,0.472470390759513,0.511758497902849,0.464753219189882,0.380891725132946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3371556",0.178786123324952,"Cellular response to heat stress",0.499220521760078,0.582540769255921,0.539477892691927,0.808356577668708,0.526995287866211,0.344467704210139,0.283785108233861,0.552070781985243,0.50893668098751,0.431458463174416,0.372371928944439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6811442",0.179639799994237,"Intra-Golgi and retrograde Golgi-to-ER traffic",0.869561212094976,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8856688",0.179639799994237,"Golgi-to-ER retrograde transport",0.869561212094976,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5653656",0.196600108090406,"Vesicle-mediated transport",0.629849855010004,0.879370430160258,0.879943791094971,0.832867188229302,0.769554728001941,0.637601415256697,0.52997491894985,0.514018497816694,0.464753219189882,0.380891725132946,0.300479001875006,0.185298767969735,0.419882361666395,0.38539415532205,0.351153965269719,0.331080025521752,0.231127568858474,0.193303978557517,0.193303978557517,0.151984773649861,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-190840",0.208929990235349,"Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane",0.784003624607995,0.894760463349064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-190861",0.208929990235349,"Gap junction assembly",0.784003624607995,0.894760463349064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-190872",0.208929990235349,"Transport of connexons to the plasma membrane",0.784003624607995,0.894760463349064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2559583",0.23153286036935,"Cellular Senescence",0.582090361720143,0.582540769255921,0.424474794772629,0.244715341529656,0.260796603998253,0.144950881524306,0.109383794054803,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6807878",0.251193937673032,"COPI-mediated anterograde transport",0.826625659688448,0.899463065726426,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6811436",0.251193937673032,"COPI-independent Golgi-to-ER retrograde traffic",0.826625659688448,0.899463065726426,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8955332",0.251193937673032,"Carboxyterminal post-translational modifications of tubulin",0.826625659688448,0.899463065726426,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2262752",0.251193937673032,"Cellular responses to stress",0.550061853461842,0.661443774851485,0.551008823243316,0.808356577668708,0.626611620852758,0.344467704210139,0.207729745341857,0.576828892269968,0.50893668098751,0.429556290783455,0.314935921447011,0.378528113078974,0.372141980164988,0.322643598962218,0.265927032548138,0.22987836563497,0.127159055329602,0.357004733964725,0.357004733964725,0.289810957004778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8953897",0.251193937673032,"Cellular responses to external stimuli",0.550061853461842,0.661443774851485,0.551008823243316,0.808356577668708,0.626611620852758,0.344467704210139,0.207729745341857,0.576828892269968,0.50893668098751,0.429556290783455,0.314935921447011,0.378528113078974,0.372141980164988,0.322643598962218,0.265927032548138,0.22987836563497,0.127159055329602,0.357004733964725,0.357004733964725,0.289810957004778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-199991",0.253207220639817,"Membrane Trafficking",0.672554349115747,0.879370430160258,0.877728596364184,0.808356577668708,0.742867529346039,0.618592507831744,0.510443465670531,0.513865483900248,0.464753219189882,0.380891725132946,0.300479001875006,0.177094329847815,0.401958179446387,0.373276976090886,0.335560015782454,0.316150915249843,0.220171112511058,0.187755642851636,0.187755642851636,0.147176065482782,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607,0.0606060606060607
"R-HSA-422475",0.253207220639817,"Axon guidance",0.780709584537213,0.899463065726426,0.879943791094971,0.919786751621646,0.80654729012903,0.633049929757761,0.632101855954431,0.682913834633565,0.646334611801363,0.919779027595022,0.899444569069316,0.781459810861634,0.751153760363024,0.717041772052077,0.686583682939433,0.642173977684301,0.465718399979466,0.413562119757659,0.413562119757659,0.337160181254466,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1266738",0.290778906591174,"Developmental Biology",0.756270090294359,0.895837064896582,0.86138229575964,0.844640259550575,0.699965936755003,0.506709293936433,0.472470390759513,0.552070781985243,0.647521168978344,0.864813992253315,0.809344105432319,0.876924613894829,0.853344285271607,0.825268837460113,0.791845685303573,0.752061352575304,0.581318236129136,0.514413643092795,0.514413643092795,0.423154819344338,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-190828",0.295585855083788,"Gap junction trafficking",0.83375634067628,0.913761662716825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5626467",0.295585855083788,"RHO GTPases activate IQGAPs",0.83375634067628,0.913761662716825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-166520",0.301337712325692,"Signaling by NTRKs",0.780709584537213,0.78179540673881,0.626172920265244,0.392964028048196,0.475461722879649,0.293251169091305,0.472470390759513,0.658860928707993,0.63140162201071,0.565993589414255,0.49428721264868,0.378528113078974,0.372141980164988,0.322643598962218,0.289500713475634,0.27259600289604,0.199213852166603,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-556833",0.301337712325692,"Metabolism of lipids",0.586928083684162,0.563151212119978,0.47572664288511,0.208146083129872,0.156462721191338,0.0923420759791454,0.128935346704044,0.327525322852887,0.250636891246653,0.293541269332665,0.300479001875006,0.242380444342445,0.24583792242766,0.198878358366804,0.168805960418739,0.150805204338451,0.171869924954221,0.18607802994537,0.18607802994537,0.337160181254466,0.256106840593214,0.256106840593214,0.256106840593214,0.256106840593214,0.256106840593214,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168638",0.311757751822329,"NOD1/2 Signaling Pathway",0.458414649981067,0.261593154324529,0.104772239453556,0.0477084614992267,0.0860817807263635,0.0541532835747992,0.109383794054803,0.269647862864669,0.250636891246653,0.16924286757752,0.358510322388223,0.242900803512649,0.261583695742675,0.234318189819888,0.203030842894229,0.181740282137685,0.127159055329602,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-380320",0.311757751822329,"Recruitment of NuMA to mitotic centrosomes",0.780709584537213,0.879370430160258,0.882324535494606,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-157858",0.334016472618779,"Gap junction trafficking and regulation",0.83417462842507,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-445144",0.334016472618779,"Signal transduction by L1",0.83417462842507,0.779909412704378,0.667201985042626,0.844640259550575,0.699965936755003,0.576203072096637,0.497199393992069,0.513865483900248,0.464753219189882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1606322",0.334016472618779,"ZBP1(DAI) mediated induction of type I IFNs",0.734615448477808,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1679131",0.334016472618779,"Trafficking and processing of endosomal TLR",0.734615448477808,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3899300",0.334016472618779,"SUMOylation of transcription cofactors",0.499220521760078,0.661443774851485,0.501338948920119,0.305812138090408,0.256082240270674,0.142706037774409,0.109383794054803,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-425393",0.334016472618779,"Transport of inorganic cations/anions and amino acids/oligopeptides",0.734615448477808,0.661443774851485,0.84957811135087,0.808356577668708,0.638355080296284,0.503612405993106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8939243",0.334016472618779,"RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known",0.499220521760078,0.459809179365728,0.257997898356912,0.305812138090408,0.256082240270674,0.142706037774409,0.109383794054803,0.253158284005796,0.222356097045719,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9609736",0.336473343425568,"Assembly and cell surface presentation of NMDA receptors",0.784003624607995,0.879370430160258,0.882324535494606,0.877816783476576,0.742174689582371,0.637601415256697,0.546313919053309,0.552070781985243,0.50893668098751,0.43141687690711,0.369204650416505,0.249063259905821,0.267170944651753,0.239794616412701,0.207844027349571,0.186109910738307,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112315",0.361314361454149,"Transmission across Chemical Synapses",0.655355909332317,0.899463065726426,0.879943791094971,0.808356577668708,0.654583079127524,0.442132095721254,0.606337724071763,0.552070781985243,0.50555438951476,0.388896346729287,0.300479001875006,0.166037434870329,0.331784770590752,0.293867613435471,0.244562664541365,0.201581801731361,0.371017637443552,0.332028566708071,0.332028566708071,0.264761725182341,0.192368972746331,0.192368972746331,0.192368972746331,0.192368972746331,0.192368972746331,0.0998217468805705,0.0998217468805705,0.0998217468805705,0.0998217468805705,0.0998217468805705,0.0998217468805705,0.0998217468805705,0.0998217468805705
"R-HSA-199977",0.376465291454066,"ER to Golgi Anterograde Transport",0.83417462842507,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1592389",0.376465291454066,"Activation of Matrix Metalloproteinases",0.655355909332317,0.582540769255921,0.424474794772629,0.34066614655568,0.751605616697239,0.645257801420276,0.551852760556947,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5663220",0.376465291454066,"RHO GTPases Activate Formins",0.823664678408998,0.879370430160258,0.883913128240566,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1538133",0.389304548843113,"G0 and Early G1",0.535490848519432,0.563151212119978,0.510255783536762,0.808356577668708,0.644881392819249,0.528433927898645,0.470157237282471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-381119",0.389304548843113,"Unfolded Protein Response (UPR)",0.535490848519432,0.661443774851485,0.510255783536762,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5357956",0.389304548843113,"TNFR1-induced NFkappaB signaling pathway",0.535490848519432,0.661443774851485,0.510255783536762,0.34066614655568,0.256082240270674,0.144950881524306,0.470157237282471,0.511758497902849,0.464753219189882,0.380891725132946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-622312",0.389304548843113,"Inflammasomes",0.766529396366599,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6791312",0.403019745193349,"TP53 Regulates Transcription of Cell Cycle Genes",0.734615448477808,0.661443774851485,0.501338948920119,0.586260934136991,0.378313148680896,0.257018995838561,0.19603737685714,0.514018497816694,0.464753219189882,0.392800805115322,0.314935921447011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6802946",0.403019745193349,"Signaling by moderate kinase activity BRAF mutants",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6802949",0.403019745193349,"Signaling by RAS mutants",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6802955",0.403019745193349,"Paradoxical activation of RAF signaling by kinase inactive BRAF",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9649948",0.403019745193349,"Signaling downstream of RAS mutants",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112314",0.406329248107665,"Neurotransmitter receptors and postsynaptic signal transmission",0.655355909332317,0.92160488927828,0.891762858828263,0.876871139744132,0.786669450622248,0.637601415256697,0.5134703939704,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.154826047396429,0.267170944651753,0.234318189819888,0.196478933589034,0.162106405773603,0.316202198428231,0.281400755722013,0.281400755722013,0.222961083845426,0.164910901467506,0.164910901467506,0.164910901467506,0.164910901467506,0.164910901467506,0.0866161616161617,0.0866161616161617,0.0866161616161617,0.0866161616161617,0.0866161616161617,0.0866161616161617,0.0866161616161617,0.0866161616161617
"R-HSA-2132295",0.419667799855458,"MHC class II antigen presentation",0.919708194434206,0.91088401206522,0.936778462322142,0.964519412071669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-211945",0.424513129468526,"Phase I - Functionalization of compounds",0.499220521760078,0.582540769255921,0.29699565006995,0.0956770071024977,0.0584132629222392,0.0187553342138674,0.109383794054803,0.253158284005796,0.464753219189882,0.380891725132946,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.197386758681406,0.18607802994537,0.18607802994537,0.136464787174491,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-381340",0.424513129468526,"Transcriptional regulation of white adipocyte differentiation",0.672554349115747,0.716234566421771,0.551008823243316,0.372414764103453,0.564248980757736,0.378411435353283,0.309255940900813,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3000171",0.424513129468526,"Non-integrin membrane-ECM interactions",0.550061853461842,0.879370430160258,0.84957811135087,0.808356577668708,0.654583079127524,0.542975842601393,0.472470390759513,0.511758497902849,0.464753219189882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3371453",0.424513129468526,"Regulation of HSF1-mediated heat shock response",0.780709584537213,0.677707654447508,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5674135",0.424513129468526,"MAP2K and MAPK activation",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5696398",0.424513129468526,"Nucleotide Excision Repair",0.780709584537213,0.677707654447508,0.84957811135087,0.808356577668708,0.654583079127524,0.542975842601393,0.472470390759513,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6802948",0.424513129468526,"Signaling by high-kinase activity BRAF mutants",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9006934",0.425251767182583,"Signaling by Receptor Tyrosine Kinases",0.671815029598206,0.661443774851485,0.501338948920119,0.677647348169244,0.699965936755003,0.557904619573744,0.527397834698068,0.590594998033563,0.541500766417338,0.650690131647037,0.575559695849727,0.72289937558914,0.690517928160569,0.66241674126285,0.623212572360034,0.578651246986431,0.420186891615893,0.362494960404,0.362494960404,0.294353660754494,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1483255",0.425251767182583,"PI Metabolism",0.900269033457811,0.852716028900849,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2559582",0.425251767182583,"Senescence-Associated Secretory Phenotype (SASP)",0.734615448477808,0.852716028900849,0.7293124826145,0.617195015102033,0.699965936755003,0.586930366298237,0.510443465670531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3247509",0.426635916981742,"Chromatin modifying enzymes",0.737706219453825,0.879370430160258,0.7293124826145,0.509742250173223,0.564248980757736,0.57843756333917,0.497199393992069,0.682913834633565,0.650977340951355,0.602982690270335,0.530994639876767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-4839726",0.426635916981742,"Chromatin organization",0.737706219453825,0.879370430160258,0.7293124826145,0.509742250173223,0.564248980757736,0.57843756333917,0.497199393992069,0.682913834633565,0.650977340951355,0.602982690270335,0.530994639876767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1483257",0.426635916981742,"Phospholipid metabolism",0.869561212094976,0.779909412704378,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.706224996907842,0.652302183375907,0.624875667931775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-73887",0.458202854860314,"Death Receptor Signalling",0.655355909332317,0.677707654447508,0.501338948920119,0.586260934136991,0.644881392819249,0.503612405993106,0.669508335106427,0.598558472890126,0.569915937955351,0.503485237639301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6802957",0.458202854860314,"Oncogenic MAPK signaling",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3371571",0.458202854860314,"HSF1-dependent transactivation",0.586928083684162,0.697963899815732,0.551008823243316,0.394992370916407,0.265099329858385,0.170911689843922,0.135873357014992,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-380259",0.458202854860314,"Loss of Nlp from mitotic centrosomes",0.784003624607995,0.697963899815732,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-380284",0.458202854860314,"Loss of proteins required for interphase microtubule organization from the centrosome",0.784003624607995,0.697963899815732,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-450302",0.458202854860314,"activated TAK1 mediates p38 MAPK activation",0.586928083684162,0.582540769255921,0.424474794772629,0.208146083129872,0.122735027801304,0.0732529710878121,0.0769133184665964,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-450321",0.458202854860314,"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1",0.784003624607995,0.697963899815732,0.551008823243316,0.394992370916407,0.265099329858385,0.170911689843922,0.135873357014992,0.253158284005796,0.222356097045719,0.136958270860816,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-75893",0.458202854860314,"TNF signaling",0.586928083684162,0.697963899815732,0.551008823243316,0.394992370916407,0.265099329858385,0.170911689843922,0.483421346151522,0.511758497902849,0.464753219189882,0.380891725132946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168256",0.464183503361806,"Immune System",0.900269033457811,0.881555317213799,0.874856894668625,0.82674313581141,0.786669450622248,0.556924821854031,0.510443465670531,0.552070781985243,0.489087041633317,0.40618162373004,0.373307456994611,0.693994243225424,0.627947727864348,0.567148543451698,0.7562077802513,0.690976980494333,0.421004973623451,0.717540973765608,0.717540973765608,0.612403447333917,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-446203",0.467642374424715,"Asparagine N-linked glycosylation",0.83417462842507,0.879370430160258,0.9038457857458,0.916366573753006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5617833",0.467642374424715,"Cilium Assembly",0.83417462842507,0.879370430160258,0.9038457857458,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-453274",0.47616824565929,"Mitotic G2-G2/M phases",0.784003624607995,0.852716028900849,0.879943791094971,0.877816783476576,0.699965936755003,0.573009717554464,0.472470390759513,0.552070781985243,0.50893668098751,0.431458463174416,0.641187882853765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69275",0.47616824565929,"G2/M Transition",0.784003624607995,0.852716028900849,0.879943791094971,0.877816783476576,0.699965936755003,0.573009717554464,0.472470390759513,0.552070781985243,0.50893668098751,0.431458463174416,0.641187882853765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-74751",0.486487179455499,"Insulin receptor signalling cascade",0.780709584537213,0.661443774851485,0.796027736576111,0.877816783476576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-74752",0.486487179455499,"Signaling by Insulin receptor",0.780709584537213,0.661443774851485,0.796027736576111,0.877816783476576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-948021",0.486487179455499,"Transport to the Golgi and subsequent modification",0.93951597595445,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6811558",0.490087839673093,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.939891463782016,0.879370430160258,0.879943791094971,0.967023012148636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-165159",0.490087839673093,"mTOR signalling",0.629849855010004,0.582540769255921,0.424474794772629,0.208146083129872,0.288008974179847,0.189769369532652,0.142507981222421,0.253158284005796,0.222356097045719,0.136958270860816,0.223350391190821,0.070810557308879,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-5617472",0.490087839673093,"Activation of anterior HOX genes in hindbrain development during early embryogenesis",0.629849855010004,0.582540769255921,0.424474794772629,0.208146083129872,0.122735027801304,0.0732529710878121,0.0769133184665964,0.253158284005796,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5619507",0.490087839673093,"Activation of HOX genes during differentiation",0.629849855010004,0.582540769255921,0.424474794772629,0.208146083129872,0.122735027801304,0.0732529710878121,0.0769133184665964,0.253158284005796,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5620912",0.490087839673093,"Anchoring of the basal body to the plasma membrane",0.826625659688448,0.716234566421771,0.86138229575964,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8854518",0.490087839673093,"AURKA Activation by TPX2",0.826625659688448,0.716234566421771,0.86138229575964,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112316",0.510779465452173,"Neuronal System",0.830293287590999,0.928965172116894,0.891762858828263,0.848234420420493,0.699965936755003,0.556824043657592,0.706224996907842,0.590594998033563,0.539075983901651,0.431918321082083,0.332479767883744,0.192841168627141,0.372141980164988,0.322643598962218,0.275535342070783,0.238731795202645,0.420186891615893,0.362494960404,0.362494960404,0.294353660754494,0.218643306379156,0.218643306379156,0.218643306379156,0.218643306379156,0.218643306379156,0.112345679012345,0.112345679012345,0.112345679012345,0.112345679012345,0.112345679012345,0.112345679012345,0.112345679012345,0.112345679012345
"R-HSA-69278",0.511879963928578,"Cell Cycle, Mitotic",0.784003624607995,0.716234566421771,0.84957811135087,0.964519412071669,0.759630949619672,0.586930366298237,0.497199393992069,0.552070781985243,0.50893668098751,0.60399340445479,0.809952144619835,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-983231",0.524698765758722,"Factors involved in megakaryocyte development and platelet production",0.975756328262555,0.964398741874844,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1280215",0.536969288313328,"Cytokine Signaling in Immune system",0.939891463782016,0.879370430160258,0.84957811135087,0.82674313581141,0.769554728001941,0.576203072096637,0.517972848789786,0.552070781985243,0.494954112769311,0.380891725132946,0.369204650416505,0.606261657892547,0.554250688957895,0.50485430012174,0.440637241269933,0.39229495064497,0.22008129491053,0.507671181343874,0.507671181343874,0.416828921200949,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112310",0.536969288313328,"Neurotransmitter release cycle",0.83375634067628,0.756841903252682,0.643324367445842,0.485622670468792,0.300579068347037,0.195985227995601,0.497199393992069,0.511758497902849,0.464753219189882,0.380891725132946,0.304903302159194,0.194629179672504,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-380270",0.536969288313328,"Recruitment of mitotic centrosome proteins and complexes",0.83375634067628,0.756841903252682,0.877728596364184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-380287",0.536969288313328,"Centrosome maturation",0.83375634067628,0.756841903252682,0.877728596364184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-442742",0.536969288313328,"CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling",0.83375634067628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5621575",0.536969288313328,"CD209 (DC-SIGN) signaling",0.655355909332317,0.582540769255921,0.439045636446885,0.211920508869613,0.300579068347037,0.195985227995601,0.149014423527745,0.511758497902849,0.464753219189882,0.380891725132946,0.304903302159194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2559580",0.551340272520205,"Oxidative Stress Induced Senescence",0.900269033457811,0.829607551537263,0.691818274392916,0.494788540905691,0.288008974179847,0.170911689843922,0.128935346704044,0.435803259139404,0.410675418254177,0.284721606787481,0.300479001875006,0.154826047396429,0.181074940126864,0.147972261504434,0.115526741495597,0.100064839560178,0.0380077350767509,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2187338",0.551340272520205,"Visual phototransduction",0.939891463782016,0.928965172116894,0.882324535494606,0.877816783476576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1474244",0.55455906503521,"Extracellular matrix organization",0.766529396366599,0.817802202525546,0.841808836097783,0.808356577668708,0.865794079938095,0.728329681058949,0.606337724071763,0.781836679838685,0.753874646672255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8852276",0.568501300638468,"The role of GTSE1 in G2/M progression after G2 checkpoint",0.909503208975638,0.92160488927828,0.916648043508376,0.972059206785082,0.897897463723135,0.836131984560791,0.756340021736338,0.718787831778118,0.688303378228243,0.635591139066016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-199418",0.568501300638468,"Negative regulation of the PI3K/AKT network",0.939891463782016,0.879370430160258,0.879943791094971,0.967023012148636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2219528",0.568501300638468,"PI3K/AKT Signaling in Cancer",0.756270090294359,0.661443774851485,0.551008823243316,0.967023012148636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-190236",0.581560218774844,"Signaling by FGFR",0.83417462842507,0.779909412704378,0.667201985042626,0.844640259550575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-445989",0.581560218774844,"TAK1 activates NFkB by phosphorylation and activation of IKKs complex",0.83417462842507,0.779909412704378,0.667201985042626,0.509742250173223,0.699965936755003,0.576203072096637,0.497199393992069,0.513865483900248,0.464753219189882,0.388654633469775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5628897",0.581560218774844,"TP53 Regulates Metabolic Genes",0.655355909332317,0.647546050018658,0.47572664288511,0.222361167603081,0.326841951854083,0.21723894295461,0.165404964775602,0.253158284005796,0.222356097045719,0.136958270860816,0.223350391190821,0.070810557308879,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442,0.0444444444444442
"R-HSA-400253",0.583868533596678,"Circadian Clock",0.655355909332317,0.582540769255921,0.539477892691927,0.808356577668708,0.526995287866211,0.344467704210139,0.283785108233861,0.552070781985243,0.50893668098751,0.431458463174416,0.372371928944439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-109704",0.650249274850278,"PI3K Cascade",0.673842423747108,0.661443774851485,0.691818274392916,0.848234420420493,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-211859",0.650803679700766,"Biological oxidations",0.631231485967968,0.661443774851485,0.444768877488914,0.208146083129872,0.0860817807263635,0.0447058241282237,0.120640821913982,0.269647862864669,0.464753219189882,0.380891725132946,0.300479001875006,0.162796895051925,0.185806537196551,0.152173162161129,0.119069604597036,0.102038042449496,0.214892499838315,0.187755642851636,0.187755642851636,0.139436030041763,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,0.111602424638445,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-15869",0.674028469904604,"Metabolism of nucleotides",0.83375634067628,0.879370430160258,0.894991750459164,0.898460182017812,0.769554728001941,0.656166728880484,0.570457963894926,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9006936",0.674028469904604,"Signaling by TGF-beta family members",0.83375634067628,0.938790285187073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112409",0.674028469904604,"RAF-independent MAPK1/3 activation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1912408",0.674028469904604,"Pre-NOTCH Transcription and Translation",0.734615448477808,0.661443774851485,0.501338948920119,0.305812138090408,0.256082240270674,0.142706037774409,0.109383794054803,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3214842",0.674028469904604,"HDMs demethylate histones",0.734615448477808,0.879370430160258,0.84957811135087,0.808356577668708,0.638355080296284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5357905",0.674028469904604,"Regulation of TNFR1 signaling",0.734615448477808,0.879370430160258,0.84957811135087,0.808356577668708,0.638355080296284,0.503612405993106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5696399",0.674028469904604,"Global Genome Nucleotide Excision Repair (GG-NER)",0.939891463782016,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69205",0.674028469904604,"G1/S-Specific Transcription",0.734615448477808,0.661443774851485,0.501338948920119,0.808356577668708,0.638355080296284,0.503612405993106,0.458865838095113,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-933542",0.674028469904604,"TRAF6 mediated NF-kB activation",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-982772",0.674028469904604,"Growth hormone receptor signaling",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112399",0.674028469904604,"IRS-mediated signalling",0.734615448477808,0.661443774851485,0.727443223401146,0.868385267215948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2871796",0.674028469904604,"FCERI mediated MAPK activation",0.999642654907109,0.92160488927828,0.879943791094971,0.868385267215948,0.699965936755003,0.580230929094453,0.510443465670531,0.514018497816694,0.464753219189882,0.392800805115322,0.314935921447011,0.214434469355957,0.239026254365208,0.213831941087614,0.185036716747742,0.162106405773603,0.119909527796692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-68886",0.674028469904604,"M Phase",0.939891463782016,0.879370430160258,0.879943791094971,0.967023012148636,0.865794079938095,0.773008989981559,0.646293346150556,0.561925134279005,0.50893668098751,0.705976925576975,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1474228",0.677254478621386,"Degradation of the extracellular matrix",0.900783661360099,0.815641950445133,0.643324367445842,0.808356577668708,0.865794079938095,0.795764756548785,0.712866914842587,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2219530",0.696994850310338,"Constitutive Signaling by Aberrant PI3K in Cancer",0.83417462842507,0.749092270842299,0.84957811135087,0.907404860323179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1430728",0.696994850310338,"Metabolism",0.766529396366599,0.697963899815732,0.844358503295017,0.497580264758012,0.437259048350247,0.298442845037346,0.458865838095113,0.552070781985243,0.569915937955351,0.539353264922823,0.373307456994611,0.458782445557616,0.399027885104285,0.328419457848676,0.265927032548138,0.21103183501892,0.421004973623451,0.335429159307326,0.335429159307326,0.612403447333917,0.465313512483324,0.465313512483324,0.465313512483324,0.465313512483324,0.465313512483324,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2404192",0.704287483006462,"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.734615448477808,0.661443774851485,0.7293124826145,0.868385267215948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2428924",0.704287483006462,"IGF1R signaling cascade",0.734615448477808,0.661443774851485,0.7293124826145,0.868385267215948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2428928",0.704287483006462,"IRS-related events triggered by IGF1R",0.734615448477808,0.661443774851485,0.7293124826145,0.868385267215948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6802952",0.704287483006462,"Signaling by BRAF and RAF fusions",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9614085",0.704287483006462,"FOXO-mediated transcription",0.734615448477808,0.661443774851485,0.501338948920119,0.617195015102033,0.409074618228684,0.278866963697474,0.207729745341857,0.514018497816694,0.478127929998751,0.400054673502624,0.323968138158829,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1640170",0.704287483006462,"Cell Cycle",0.83417462842507,0.852716028900849,0.877728596364184,0.967023012148636,0.813775229019967,0.646671425287608,0.510443465670531,0.582414318527799,0.517880863539893,0.645595898828105,0.844465109368107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1912422",0.704287483006462,"Pre-NOTCH Expression and Processing",0.766529396366599,0.661443774851485,0.510255783536762,0.34066614655568,0.256082240270674,0.144950881524306,0.120640821913982,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2029482",0.704287483006462,"Regulation of actin dynamics for phagocytic cup formation",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-204998",0.704287483006462,"Cell death signalling via NRAGE, NRIF and NADE",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-211981",0.704287483006462,"Xenobiotics",0.766529396366599,0.661443774851485,0.510255783536762,0.34066614655568,0.256082240270674,0.144950881524306,0.120640821913982,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.189676443469657,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.108317687617588,0.18607802994537,0.18607802994537,0.136464787174491,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,0.0912019566736558,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2173793",0.704287483006462,"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer",0.766529396366599,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5260271",0.704287483006462,"Diseases of Immune System",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5602358",0.704287483006462,"Diseases associated with the TLR signaling cascade",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-194138",0.705560577278625,"Signaling by VEGF",0.673842423747108,0.582540769255921,0.424474794772629,0.149795218616741,0.144775061854831,0.0732529710878121,0.109383794054803,0.253158284005796,0.222356097045719,0.380891725132946,0.300479001875006,0.381023498063304,0.372141980164988,0.328419457848676,0.298717623892648,0.281194127905283,0.205057411600876,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-109606",0.733450004760223,"Intrinsic Pathway for Apoptosis",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-170834",0.733450004760223,"Signaling by TGF-beta Receptor Complex",0.909503208975638,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2122947",0.733450004760223,"NOTCH1 Intracellular Domain Regulates Transcription",0.766529396366599,0.879370430160258,0.772909080623957,0.646800075454479,0.433831449401872,0.293251169091305,0.220316593924817,0.532042034394775,0.490697907683551,0.402833209869921,0.332479767883744,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-186712",0.757599387609164,"Regulation of beta-cell development",0.780709584537213,0.677707654447508,0.539477892691927,0.372414764103453,0.256082240270674,0.160750942287644,0.128935346704044,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3781865",0.757599387609164,"Diseases of glycosylation",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5693607",0.757599387609164,"Processing of DNA double-strand break ends",0.780709584537213,0.677707654447508,0.84957811135087,0.808356577668708,0.654583079127524,0.542975842601393,0.472470390759513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-881907",0.757599387609164,"Gastrin-CREB signalling pathway via PKC and MAPK",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9008059",0.757599387609164,"Interleukin-37 signaling",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-168249",0.757599387609164,"Innate Immune System",0.900269033457811,0.91088401206522,0.874856894668625,0.808356577668708,0.699965936755003,0.466265415095403,0.418230442201429,0.514018497816694,0.464753219189882,0.402833209869921,0.417673303393462,0.41498414714308,0.372141980164988,0.322643598962218,0.50908313207588,0.446413634561966,0.241254952386139,0.544137989137548,0.544137989137548,0.450601096140607,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-373755",0.771891443766512,"Semaphorin interactions",0.93951597595445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-449147",0.789396621893325,"Signaling by Interleukins",0.983346019094845,0.92160488927828,0.860243581446008,0.808356577668708,0.641192338720156,0.378411435353283,0.393698763492739,0.511758497902849,0.464753219189882,0.288744679502121,0.300479001875006,0.458782445557616,0.426093362203397,0.381048110894758,0.330670342474198,0.288840800094653,0.171869924954221,0.413562119757659,0.413562119757659,0.337160181254466,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-71387",0.789396621893325,"Metabolism of carbohydrates",0.939891463782016,0.879370430160258,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.705469537515335,0.634397087861755,0.607155350437813,0.539353264922823,0.470147976514208,0.367135950394154,0.372141980164988,0.322643598962218,0.279434085277651,0.26321119628442,0.196403197610657,0.18607802994537,0.18607802994537,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-73894",0.789396621893325,"DNA Repair",0.939891463782016,0.879370430160258,0.879943791094971,0.844640259550575,0.69196449886185,0.542975842601393,0.470157237282471,0.634397087861755,0.607155350437813,0.539353264922823,0.470147976514208,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-392499",0.789396621893325,"Metabolism of proteins",0.900269033457811,0.879370430160258,0.84957811135087,0.898460182017812,0.952349709506681,0.885054622350859,0.756340021736338,0.899637976187295,0.86275229822043,0.909745859220711,0.973531129970767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3108232",0.789396621893325,"SUMO E3 ligases SUMOylate target proteins",0.830293287590999,0.815641950445133,0.84957811135087,0.82677245710523,0.763247949682011,0.637601415256697,0.526772593502827,0.729524341313043,0.69920285961813,0.645595898828105,0.583146478969293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-194068",0.789396621893325,"Bile acid and bile salt metabolism",0.784003624607995,0.697963899815732,0.551008823243316,0.394992370916407,0.677120060272741,0.556824043657592,0.483421346151522,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2151201",0.789396621893325,"Transcriptional activation of mitochondrial biogenesis",0.784003624607995,0.697963899815732,0.84957811135087,0.82674313581141,0.677120060272741,0.556824043657592,0.483421346151522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5654738",0.789396621893325,"Signaling by FGFR2",0.961334451976328,0.894760463349064,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5654743",0.789396621893325,"Signaling by FGFR4",0.961334451976328,0.894760463349064,0.84957811135087,0.82674313581141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5673000",0.789396621893325,"RAF activation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5674400",0.789396621893325,"Constitutive Signaling by AKT1 E17K in Cancer",0.784003624607995,0.697963899815732,0.551008823243316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9029569",0.789396621893325,"NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",0.784003624607995,0.894760463349064,0.84957811135087,0.82674313581141,0.677120060272741,0.556824043657592,0.483421346151522,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1989781",0.820335300162424,"PPARA activates gene expression",0.780709584537213,0.852716028900849,0.84957811135087,0.808356577668708,0.638355080296284,0.466265415095403,0.388237389265019,0.582414318527799,0.544703189361728,0.482550241827368,0.413774505911305,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-400206",0.820335300162424,"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)",0.780709584537213,0.852716028900849,0.84957811135087,0.808356577668708,0.638355080296284,0.466265415095403,0.388237389265019,0.582414318527799,0.544703189361728,0.482550241827368,0.413774505911305,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1483206",0.832895628900742,"Glycerophospholipid biosynthesis",0.939891463782016,0.879370430160258,0.84957811135087,0.877816783476576,0.742174689582371,0.637601415256697,0.546313919053309,0.552070781985243,0.50893668098751,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-381426",0.832895628900742,"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",0.939891463782016,0.928965172116894,0.882324535494606,0.877816783476576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-140877",0.835941347957804,"Formation of Fibrin Clot (Clotting Cascade)",0.826625659688448,0.716234566421771,0.597974737028787,0.832867188229302,0.69196449886185,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3214841",0.835941347957804,"PKMTs methylate histone lysines",0.972005494247293,0.899463065726426,0.86138229575964,0.832867188229302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69473",0.835941347957804,"G2/M DNA damage checkpoint",0.972005494247293,0.899463065726426,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9012852",0.835941347957804,"Signaling by NOTCH3",0.826625659688448,0.716234566421771,0.597974737028787,0.443342241744138,0.288008974179847,0.189769369532652,0.142507981222421,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2990846",0.84488339289987,"SUMOylation",0.83417462842507,0.852716028900849,0.84957811135087,0.843140102777115,0.781000107240481,0.646671425287608,0.538217978307992,0.742438789850326,0.712475922881203,0.650690131647037,0.595639092361826,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-4420097",0.855702063481561,"VEGFA-VEGFR2 Pathway",0.780709584537213,0.661443774851485,0.501338948920119,0.222361167603081,0.256082240270674,0.142706037774409,0.207729745341857,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.378528113078974,0.372141980164988,0.322643598962218,0.289500713475634,0.27259600289604,0.199213852166603,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-193704",0.859256956282128,"p75 NTR receptor-mediated signalling",0.939891463782016,0.879370430160258,0.84957811135087,0.888479927211296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5619102",0.859256956282128,"SLC transporter disorders",0.999642654907109,0.928965172116894,0.883913128240566,0.888479927211296,0.751605616697239,0.645257801420276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1226099",0.880964670800301,"Signaling by FGFR in disease",0.83375634067628,0.756841903252682,0.643324367445842,0.844640259550575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2514856",0.880964670800301,"The phototransduction cascade",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2514859",0.880964670800301,"Inactivation, recovery and regulation of the phototransduction cascade",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-446652",0.920495553419904,"Interleukin-1 family signaling",0.999642654907109,0.961513504436204,0.891762858828263,0.967023012148636,0.937093632973288,0.895976314303141,0.837241377843005,0.782965592265519,0.755228437305369,0.691614590558591,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5663202",0.920495553419904,"Diseases of signal transduction",0.982491131545384,0.92160488927828,0.879943791094971,0.974946573991781,0.955905627879253,0.928410194551181,0.854503546507954,0.943536633928799,0.925948985042711,0.888307929315596,0.854236609070555,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5693567",0.926194530016084,"HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",0.83417462842507,0.779909412704378,0.879943791094971,0.844640259550575,0.699965936755003,0.576203072096637,0.497199393992069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6804757",0.926194530016084,"Regulation of TP53 Degradation",0.83417462842507,0.779909412704378,0.879943791094971,0.844640259550575,0.699965936755003,0.576203072096637,0.497199393992069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6806003",0.926194530016084,"Regulation of TP53 Expression and Degradation",0.83417462842507,0.779909412704378,0.879943791094971,0.844640259550575,0.699965936755003,0.576203072096637,0.497199393992069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-913531",0.926194530016084,"Interferon Signaling",0.939891463782016,0.879370430160258,0.84957811135087,0.898460182017812,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6785807",0.926194530016084,"Interleukin-4 and Interleukin-13 signaling",0.99293394154518,0.994098048912689,0.965846011743826,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,0.682913834633565,0.648612394592183,0.596433673788012,0.521883996420851,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-196854",0.926194530016084,"Metabolism of vitamins and cofactors",0.83375634067628,0.879370430160258,0.796027736576111,0.627758759623285,0.654583079127524,0.779853710527778,0.691394133091648,0.61936775818251,0.588377476372218,0.522342321025885,0.451900137467758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2029480",0.926194530016084,"Fcgamma receptor (FCGR) dependent phagocytosis",0.946979328362833,0.94315675060462,0.900565341672882,0.907404860323179,0.781000107240481,0.664571807738162,0.580448952654875,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,0.279418453858252,0.293972605213476,0.268386037636124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2644602",0.926194530016084,"Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.564248980757736,0.378411435353283,0.310142295507222,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2644603",0.926194530016084,"Signaling by NOTCH1 in Cancer",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.564248980757736,0.378411435353283,0.310142295507222,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2644606",0.926194530016084,"Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.564248980757736,0.378411435353283,0.310142295507222,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2894858",0.926194530016084,"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.564248980757736,0.378411435353283,0.310142295507222,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2894862",0.926194530016084,"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.564248980757736,0.378411435353283,0.310142295507222,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-597592",0.926194530016084,"Post-translational protein modification",0.975756328262555,0.928965172116894,0.951389026286704,0.967023012148636,0.916740606364936,0.828746570009416,0.713767772703925,0.899637976187295,0.865558087764796,0.792488523163152,0.928843329453369,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1660499",0.926194530016084,"Synthesis of PIPs at the plasma membrane",0.999642654907109,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-212165",0.926194530016084,"Epigenetic regulation of gene expression",0.83417462842507,0.815641950445133,0.691818274392916,0.848234420420493,0.699965936755003,0.576203072096637,0.503886038725953,0.513865483900248,0.464753219189882,0.388896346729287,0.314935921447011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-350054",0.926194530016084,"Notch-HLH transcription pathway",0.83417462842507,0.92160488927828,0.879943791094971,0.848234420420493,0.699965936755003,0.576203072096637,0.503886038725953,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-375165",0.926194530016084,"NCAM signaling for neurite out-growth",0.999642654907109,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5576892",0.926194530016084,"Phase 0 - rapid depolarisation",0.83417462842507,0.815641950445133,0.691818274392916,0.848234420420493,0.699965936755003,0.576203072096637,0.503886038725953,0.513865483900248,0.464753219189882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-76009",0.926194530016084,"Platelet Aggregation (Plug Formation)",0.83417462842507,0.815641950445133,0.691818274392916,0.848234420420493,0.699965936755003,0.576203072096637,0.503886038725953,0.513865483900248,0.464753219189882,0.388896346729287,0.314935921447011,0.211283731212337,0.231220494866708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9024446",0.926194530016084,"NR1H2 and NR1H3-mediated signaling",0.83417462842507,0.92160488927828,0.879943791094971,0.848234420420493,0.699965936755003,0.576203072096637,0.503886038725953,0.513865483900248,0.464753219189882,0.388896346729287,0.314935921447011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-383280",0.94960254517915,"Nuclear Receptor transcription pathway",0.83417462842507,0.879370430160258,0.879943791094971,0.967023012148636,0.865794079938095,0.784513724150065,0.696433236833764,0.623354196359245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1980143",0.949887307786546,"Signaling by NOTCH1",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.58370580337743,0.393092488026022,0.322110994519073,0.552070781985243,0.50893668098751,0.438788638992205,0.378656956569802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5693532",0.949887307786546,"DNA Double-Strand Break Repair",0.961334451976328,0.879370430160258,0.9038457857458,0.916366573753006,0.786669450622248,0.674420539678325,0.593099615111703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9018519",0.949887307786546,"Estrogen-dependent gene expression",0.83417462842507,0.879370430160258,0.84957811135087,0.808356577668708,0.58370580337743,0.393092488026022,0.322110994519073,0.552070781985243,0.50893668098751,0.438788638992205,0.378656956569802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1500931",0.956866025322495,"Cell-Cell communication",0.869561212094976,0.852716028900849,0.727443223401146,0.868385267215948,0.699965936755003,0.580230929094453,0.510443465670531,0.514018497816694,0.464753219189882,0.392800805115322,0.314935921447011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3928662",0.956866025322495,"EPHB-mediated forward signaling",0.869561212094976,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6783783",0.956866025322495,"Interleukin-10 signaling",0.869561212094976,0.852716028900849,0.727443223401146,0.586260934136991,0.378313148680896,0.257018995838561,0.510443465670531,0.514018497816694,0.464753219189882,0.392800805115322,0.314935921447011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69620",0.961836538426786,"Cell Cycle Checkpoints",0.909503208975638,0.779909412704378,0.84957811135087,0.967023012148636,0.830300273484768,0.695474406353476,0.580018880947961,0.763864534898039,0.735300658657721,0.674924774956818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1643685",0.97531831958443,"Disease",0.999642654907109,0.928965172116894,0.894991750459164,0.972059206785082,0.990562786415412,0.988374168606471,0.987473056579072,0.991369154284351,0.987335257506032,0.972777336607459,0.969051247535791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-212436",0.979801541038532,"Generic Transcription Pathway",0.83375634067628,0.661443774851485,0.667201985042626,0.808356577668708,0.637235206075619,0.293251169091305,0.137130745370735,0.511758497902849,0.464753219189882,0.400054673502624,0.300479001875006,0.214434469355957,0.372141980164988,0.322643598962218,0.265927032548138,0.44623238021778,0.24032378090829,0.187755642851636,0.187755642851636,0.136464787174491,0.33255970910059,0.33255970910059,0.33255970910059,0.33255970910059,0.33255970910059,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976
"R-HSA-451927",0.979801541038532,"Interleukin-2 family signaling",0.900269033457811,0.852716028900849,0.7293124826145,0.868385267215948,0.699965936755003,0.586930366298237,0.510443465670531,0.514018497816694,0.478127929998751,0.400054673502624,0.323968138158829,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5362517",0.979801541038532,"Signaling by Retinoic Acid",0.900269033457811,0.852716028900849,0.7293124826145,0.617195015102033,0.699965936755003,0.586930366298237,0.510443465670531,0.514018497816694,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5693538",0.979801541038532,"Homology Directed Repair",0.900269033457811,0.852716028900849,0.879943791094971,0.868385267215948,0.699965936755003,0.586930366298237,0.510443465670531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8848021",0.979801541038532,"Signaling by PTK6",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9006927",0.979801541038532,"Signaling by Non-Receptor Tyrosine Kinases",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-73857",0.980290955232083,"RNA Polymerase II Transcription",0.83375634067628,0.661443774851485,0.667201985042626,0.808356577668708,0.638355080296284,0.295632417675206,0.137951667208581,0.511758497902849,0.464753219189882,0.400597825412685,0.300479001875006,0.214434469355957,0.372141980164988,0.322643598962218,0.265927032548138,0.44623238021778,0.24032378090829,0.187755642851636,0.187755642851636,0.136464787174491,0.33255970910059,0.33255970910059,0.33255970910059,0.33255970910059,0.33255970910059,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976
"R-HSA-5673001",0.980648088085742,"RAF/MAP kinase cascade",0.999642654907109,0.925506633494393,0.920931561165728,0.98940483548894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8957322",0.980648088085742,"Metabolism of steroids",0.83417462842507,0.716234566421771,0.539477892691927,0.305812138090408,0.300579068347037,0.170911689843922,0.292250516368404,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.16386914954697,0.185806537196551,0.152173162161129,0.119069604597036,0.102038042449496,0.215337779777678,0.187755642851636,0.187755642851636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-186797",0.980648088085742,"Signaling by PDGF",0.909503208975638,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2426168",0.980648088085742,"Activation of gene expression by SREBF (SREBP)",0.909503208975638,0.879370430160258,0.772909080623957,0.646800075454479,0.433831449401872,0.293251169091305,0.522255374287068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2672351",0.980648088085742,"Stimuli-sensing channels",0.909503208975638,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-70326",0.980648088085742,"Glucose metabolism",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8856828",0.980648088085742,"Clathrin-mediated endocytosis",0.909503208975638,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-977443",0.980648088085742,"GABA receptor activation",0.909503208975638,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-425407",0.980648088085742,"SLC-mediated transmembrane transport",0.999642654907109,0.92160488927828,0.951389026286704,0.967023012148636,0.865794079938095,0.790751893858537,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9607240",0.980648088085742,"FLT3 Signaling",0.999642654907109,0.92160488927828,0.951389026286704,0.98940483548894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-74160",0.980648088085742,"Gene expression (Transcription)",0.83417462842507,0.661443774851485,0.691818274392916,0.808356577668708,0.638355080296284,0.311450781060158,0.145010734603969,0.511758497902849,0.464753219189882,0.40618162373004,0.300479001875006,0.222598170426004,0.372631201753932,0.322643598962218,0.265927032548138,0.446413634561966,0.241254952386139,0.187755642851636,0.187755642851636,0.136464787174491,0.33255970910059,0.33255970910059,0.33255970910059,0.33255970910059,0.33255970910059,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976,0.176430976430976
"R-HSA-109582",0.980648088085742,"Hemostasis",0.982491131545384,0.92160488927828,0.882324535494606,0.972059206785082,0.865794079938095,0.840088214665176,0.727892321228964,0.814822180776373,0.774337206357347,0.690099774864353,0.607563548857784,0.434376371199623,0.396858808552658,0.694197629709264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1655829",0.980648088085742,"Regulation of cholesterol biosynthesis by SREBP (SREBF)",0.93951597595445,0.879370430160258,0.796027736576111,0.6824972429629,0.458028764452191,0.298442845037346,0.52997491894985,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9006931",0.980648088085742,"Signaling by Nuclear Receptors",0.972005494247293,0.928965172116894,0.879943791094971,0.840706767703058,0.73173118323182,0.580230929094453,0.497199393992069,0.588161375246338,0.796410340759917,0.731213607418237,0.673005802024879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5684996",0.980648088085742,"MAPK1/MAPK3 signaling",0.999642654907109,0.928965172116894,0.936778462322142,0.98940483548894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1250196",0.980648088085742,"SHC1 events in ERBB2 signaling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1474165",0.980648088085742,"Reproduction",0.939891463782016,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-156580",0.980648088085742,"Phase II - Conjugation of compounds",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.638355080296284,0.503612405993106,0.458865838095113,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1980145",0.980648088085742,"Signaling by NOTCH2",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.638355080296284,0.503612405993106,0.458865838095113,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-200425",0.980648088085742,"Import of palmitoyl-CoA into the mitochondrial matrix",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2022090",0.980648088085742,"Assembly of collagen fibrils and other multimeric structures",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-210990",0.980648088085742,"PECAM1 interactions",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5250941",0.980648088085742,"Negative epigenetic regulation of rRNA expression",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5689896",0.980648088085742,"Ovarian tumor domain proteases",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-629594",0.980648088085742,"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-70268",0.980648088085742,"Pyruvate metabolism",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8941326",0.980648088085742,"RUNX2 regulates bone development",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9609507",0.980648088085742,"Protein localization",0.939891463782016,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9616222",0.980648088085742,"Transcriptional regulation of granulopoiesis",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.638355080296284,0.503612405993106,0.458865838095113,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8939211",0.980648088085742,"ESR-mediated signaling",0.999642654907109,0.967153915189011,0.907132971100221,0.898460182017812,0.740970820038184,0.608800266763861,0.510443465670531,0.715500354039504,0.684675980262272,0.632347090975128,0.562062853905356,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-418346",0.980648088085742,"Platelet homeostasis",0.919708194434206,0.852716028900849,0.727443223401146,0.808356577668708,0.638355080296284,0.479429896393006,0.39913162907752,0.588161375246338,0.554063621564558,0.491045077464923,0.417673303393462,0.319632655677185,0.331784770590752,0.301074672912132,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1442490",0.980648088085742,"Collagen degradation",0.999642654907109,0.925506633494393,0.882324535494606,0.877816783476576,0.73173118323182,0.633049929757761,0.538217978307992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1257604",0.980648088085742,"PIP3 activates AKT signaling",0.999642654907109,0.879370430160258,0.84957811135087,0.974946573991781,0.977796947060784,0.975302398739348,0.937293109369015,0.895873761004558,0.865558087764796,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-76002",0.980648088085742,"Platelet activation, signaling and aggregation",0.939891463782016,0.879370430160258,0.84957811135087,0.967023012148636,0.80654729012903,0.670984624047368,0.559895467545273,0.750234132798003,0.721256012760476,0.660495136370739,0.607563548857784,0.461290733805078,0.431761942613071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1474290",0.980648088085742,"Collagen formation",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-163560",0.980648088085742,"Triglyceride catabolism",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3000178",0.980648088085742,"ECM proteoglycans",0.939891463782016,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5625740",0.980648088085742,"RHO GTPases activate PKNs",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.644881392819249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5693565",0.980648088085742,"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5693606",0.980648088085742,"DNA Double Strand Break Response",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-622323",0.980648088085742,"Presynaptic nicotinic acetylcholine receptors",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6804760",0.980648088085742,"Regulation of TP53 Activity through Methylation",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.644881392819249,0.528433927898645,0.470157237282471,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-71406",0.980648088085742,"Pyruvate metabolism and Citric Acid (TCA) cycle",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8862803",0.980648088085742,"Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",0.939891463782016,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8863678",0.980648088085742,"Neurodegenerative Diseases",0.939891463782016,0.879370430160258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8936459",0.980648088085742,"RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.644881392819249,0.528433927898645,0.470157237282471,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8956321",0.980648088085742,"Nucleotide salvage",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9634638",0.980648088085742,"Estrogen-dependent nuclear events downstream of ESR-membrane signaling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5688426",0.980648088085742,"Deubiquitination",0.999642654907109,0.92160488927828,0.907132971100221,0.888479927211296,0.699965936755003,0.576203072096637,0.480341005007976,0.561925134279005,0.50893668098751,0.431918321082083,0.647426855658383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6798695",0.980648088085742,"Neutrophil degranulation",0.966687461093812,0.947519823183577,0.938825114372688,0.967023012148636,0.865794079938095,0.712320001580858,0.570457963894926,0.682913834633565,0.648612394592183,0.818575566357392,0.780406004086232,0.642202214653858,0.608763712501392,0.57314163074855,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2467813",0.980648088085742,"Separation of Sister Chromatids",0.999642654907109,0.981377907989218,0.982570072818887,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2555396",0.980648088085742,"Mitotic Metaphase and Anaphase",0.999642654907109,0.981377907989218,0.982570072818887,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-68882",0.980648088085742,"Mitotic Anaphase",0.999642654907109,0.981377907989218,0.982570072818887,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1428517",0.980648088085742,"The citric acid (TCA) cycle and respiratory electron transport",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-177929",0.980648088085742,"Signaling by EGFR",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-181431",0.980648088085742,"Acetylcholine binding and downstream events",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2022377",0.980648088085742,"Metabolism of Angiotensinogen to Angiotensins",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3295583",0.980648088085742,"TRP channels",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-354192",0.980648088085742,"Integrin alphaIIb beta3 signaling",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-4086398",0.980648088085742,"Ca2+ pathway",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-622327",0.980648088085742,"Postsynaptic nicotinic acetylcholine receptors",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9006921",0.980648088085742,"Integrin signaling",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-912526",0.980648088085742,"Interleukin receptor SHC signaling",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-977225",0.980648088085742,"Amyloid fiber formation",0.939891463782016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1433557",0.986536359222433,"Signaling by SCF-KIT",0.939891463782016,0.879370430160258,0.84957811135087,0.893976160937466,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-196849",0.986536359222433,"Metabolism of water-soluble vitamins and cofactors",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.555406976353201,0.64764133270203,0.559895467545273,0.552070781985243,0.50893668098751,0.431918321082083,0.373307456994611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-388841",0.986536359222433,"Costimulation by the CD28 family",0.939891463782016,0.879370430160258,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2682334",0.996239314396841,"EPH-Ephrin signaling",0.999642654907109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5654736",0.996239314396841,"Signaling by FGFR1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5654741",0.996239314396841,"Signaling by FGFR3",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-983695",0.996239314396841,"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers",0.961334451976328,0.894760463349064,0.84957811135087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-211897",0.996239314396841,"Cytochrome P450 - arranged by substrate type",0.939891463782016,0.879370430160258,0.84957811135087,0.808356577668708,0.564248980757736,0.378411435353283,0.309255940900813,0.552070781985243,0.50893668098751,0.432239177785042,0.373307456994611,0.274204673816665,0.289007824444785,0.263849305530082,0.228917521953232,0.201581801731361,0.146356529144455,0.18607802994537,0.18607802994537,0.136464787174491,0.0978525762402264,0.0978525762402264,0.0978525762402264,0.0978525762402264,0.0978525762402264,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3928665",0.996239314396841,"EPH-ephrin mediated repulsion of cells",0.999642654907109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8986944",0.999995193246982,"Transcriptional Regulation by MECP2",0.946979328362833,0.94315675060462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69206",0.999995193246982,"G1/S Transition",0.995942081467684,0.879370430160258,0.942659912250453,0.974946573991781,0.910722719230444,0.85782673447334,0.784793194945328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-418038",0.999995193246982,"Nucleotide-like (purinergic) receptors",0.972005494247293,0.899463065726426,0.86138229575964,0.832867188229302,0.69196449886185,0.565715304802097,0.497199393992069,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6794362",0.999995193246982,"Protein-protein interactions at synapses",0.972005494247293,0.899463065726426,0.86138229575964,0.832867188229302,0.69196449886185,0.565715304802097,0.497199393992069,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,0.192841168627141,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6804758",0.999995193246982,"Regulation of TP53 Activity through Acetylation",0.972005494247293,0.899463065726426,0.86138229575964,0.832867188229302,0.69196449886185,0.565715304802097,0.497199393992069,0.511758497902849,0.464753219189882,0.380891725132946,0.300479001875006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8856825",0.999995193246982,"Cargo recognition for clathrin-mediated endocytosis",0.972005494247293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8979227",0.999995193246982,"Triglyceride metabolism",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9022692",0.999995193246982,"Regulation of MECP2 expression and activity",0.972005494247293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9006925",0.999995193246982,"Intracellular signaling by second messengers",0.999642654907109,0.879370430160258,0.84957811135087,0.972059206785082,0.942998015754216,0.988374168606471,0.964470633404409,0.925241916004789,0.904829765779864,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-983712",0.999995193246982,"Ion channel transport",0.961334451976328,0.951090449786472,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5683057",0.999995193246982,"MAPK family signaling cascades",0.999642654907109,0.968834048338108,0.951389026286704,0.989410119774694,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-114608",0.999995193246982,"Platelet degranulation ",0.982755867542887,0.913761662716825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-70171",0.999995193246982,"Glycolysis",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-186763",0.999995193246982,"Downstream signal transduction",0.995657936448405,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-196071",0.999995193246982,"Metabolism of steroid hormones",0.995657936448405,0.92160488927828,0.879943791094971,0.844640259550575,0.699965936755003,0.576203072096637,0.497199393992069,0.513865483900248,0.464753219189882,0.388654633469775,0.314935921447011,0.203150071889433,0.222993017745693,0.198878358366804,0.168805960418739,0.150805204338451,0.109545956850387,0.18607802994537,0.18607802994537,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8957275",0.999995193246982,"Post-translational protein phosphorylation",0.995657936448405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-176408",0.999995193246982,"Regulation of APC/C activators between G1/S and early anaphase",0.999642654907109,0.925506633494393,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.706257086214341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-176814",0.999995193246982,"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins",0.999642654907109,0.925506633494393,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.706257086214341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69481",0.999995193246982,"G2/M Checkpoints",0.999642654907109,0.92160488927828,0.982570072818887,0.972059206785082,0.897897463723135,0.836131984560791,0.756340021736338,0.718787831778118,0.688303378228243,0.635591139066016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9009391",0.999995193246982,"Extra-nuclear estrogen signaling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-114604",0.999995193246982,"GPVI-mediated activation cascade",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-877300",0.999995193246982,"Interferon gamma signaling",0.999642654907109,0.92160488927828,0.879943791094971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5610787",0.999995193246982,"Hedgehog 'off' state",0.999642654907109,0.99702682946141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5621481",0.999995193246982,"C-type lectin receptors (CLRs)",0.999642654907109,0.914371472027386,0.84957811135087,0.808356577668708,0.698291508221487,0.542421144049815,0.451753088623981,0.552070781985243,0.50893668098751,0.402833209869921,0.621402350028738,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-76005",0.999995193246982,"Response to elevated platelet cytosolic Ca2+",0.999642654907109,0.92160488927828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8943724",0.999995193246982,"Regulation of PTEN gene transcription",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-174143",0.999995193246982,"APC/C-mediated degradation of cell cycle proteins",0.999642654907109,0.928965172116894,0.882324535494606,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-453276",0.999995193246982,"Regulation of mitotic cell cycle",0.999642654907109,0.928965172116894,0.882324535494606,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69239",0.999995193246982,"Synthesis of DNA",0.982755867542887,0.879370430160258,0.882324535494606,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69242",0.999995193246982,"S Phase",0.97326422903559,0.879370430160258,0.929672537643017,0.974946573991781,0.904131825569176,0.841647268830023,0.766459507093501,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-453279",0.999995193246982,"Mitotic G1-G1/S phases",0.999642654907109,0.92160488927828,0.951389026286704,0.974946573991781,0.932396025805834,0.887246735384397,0.82662506772262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9020702",0.999995193246982,"Interleukin-1 signaling",0.999642654907109,0.983070822292096,0.935654522237361,0.925486703701443,0.904131825569176,0.844130612614105,0.769591279929687,0.732621882461211,0.702445954151653,0.645595898828105,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-111933",0.999995193246982,"Calmodulin induced events",0.999642654907109,0.92160488927828,0.879943791094971,0.868385267215948,0.699965936755003,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-111997",0.999995193246982,"CaM pathway",0.999642654907109,0.92160488927828,0.879943791094971,0.868385267215948,0.699965936755003,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69306",0.999995193246982,"DNA Replication",0.995942081467684,0.894760463349064,0.882324535494606,0.967023012148636,0.866451391505423,0.797280423459342,0.7164041420648,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-201681",0.999995193246982,"TCF dependent signaling in response to WNT",0.983346019094845,0.879370430160258,0.84957811135087,0.832867188229302,0.644881392819249,0.470177632225939,0.367049776027923,0.514018497816694,0.464753219189882,0.648663081685384,0.593007119917295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8878171",0.999995193246982,"Transcriptional regulation by RUNX1",0.975756328262555,0.879370430160258,0.841808836097783,0.808356577668708,0.699965936755003,0.556824043657592,0.470157237282471,0.552070781985243,0.50893668098751,0.690099774864353,0.640575709198098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-425366",0.999995193246982,"Transport of bile salts and organic acids, metal ions and amine compounds",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69615",0.999995193246982,"G1/S DNA Damage Checkpoints",0.999642654907109,0.899463065726426,0.883913128240566,0.96990615964091,0.870527049022958,0.802134353180872,0.721685528183708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5358351",0.999995193246982,"Signaling by Hedgehog",0.999642654907109,0.99702682946141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-109581",0.999995193246982,"Apoptosis",0.999642654907109,0.99702682946141,0.990593327838258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-195721",0.999995193246982,"Signaling by WNT",0.999642654907109,0.92160488927828,0.874856894668625,0.877816783476576,0.699965936755003,0.565715304802097,0.470157237282471,0.552070781985243,0.50893668098751,0.693040944918875,0.641187882853765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-111996",0.999995193246982,"Ca-dependent events",0.999642654907109,0.92160488927828,0.882324535494606,0.877816783476576,0.728575798746641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112040",0.999995193246982,"G-protein mediated events",0.999642654907109,0.92160488927828,0.882324535494606,0.877816783476576,0.728575798746641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-112043",0.999995193246982,"PLC beta mediated events",0.999642654907109,0.92160488927828,0.882324535494606,0.877816783476576,0.728575798746641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1489509",0.999995193246982,"DAG and IP3 signaling",0.999642654907109,0.92160488927828,0.882324535494606,0.877816783476576,0.728575798746641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-512988",0.999995193246982,"Interleukin-3, Interleukin-5 and GM-CSF signaling",0.999642654907109,0.92160488927828,0.882324535494606,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2454202",0.999995193246982,"Fc epsilon receptor (FCERI) signaling",0.999642654907109,0.967153915189011,0.899777268596958,0.877816783476576,0.865794079938095,0.749416872098921,0.626386207780916,0.552070781985243,0.50893668098751,0.43141687690711,0.641187882853765,0.506084113741263,0.475059154493225,0.448293105617126,0.409808098813001,0.387630142103398,0.258975678552418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69202",0.999995193246982,"Cyclin E associated events during G1/S transition ",0.999642654907109,0.91088401206522,0.891762858828263,0.96990615964091,0.877876528397148,0.811089568509394,0.728281921366964,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1227986",0.999995193246982,"Signaling by ERBB2",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-4090294",0.999995193246982,"SUMOylation of intracellular receptors",0.999642654907109,0.925506633494393,0.882324535494606,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5689880",0.999995193246982,"Ub-specific processing proteases",0.999642654907109,0.928965172116894,0.945820386874736,0.964519412071669,0.792248254824841,0.656166728880484,0.551474745134908,0.74588709095997,0.716538298549552,0.651690861879102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5357801",0.999995193246982,"Programmed Cell Death",0.999642654907109,0.99702682946141,0.990593327838258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69656",0.999995193246982,"Cyclin A:Cdk2-associated events at S phase entry",0.999642654907109,0.914371472027386,0.894991750459164,0.970789076503871,0.88117090185917,0.815207565389576,0.732899465637474,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5576891",0.999995193246982,"Cardiac conduction",0.999642654907109,0.92160488927828,0.879943791094971,0.967023012148636,0.865794079938095,0.784513724150065,0.696433236833764,0.623354196359245,0.596218184117928,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1296071",0.999995193246982,"Potassium Channels",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2980736",0.999995193246982,"Peptide hormone metabolism",0.999642654907109,0.93237440079056,0.891762858828263,0.893976160937466,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-176409",0.999995193246982,"APC/C:Cdc20 mediated degradation of mitotic proteins",0.999642654907109,0.983070822292096,0.951389026286704,0.967023012148636,0.865794079938095,0.790751893858537,0.706224996907842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5607761",0.999995193246982,"Dectin-1 mediated noncanonical NF-kB signaling",0.999642654907109,0.983070822292096,0.951389026286704,0.967023012148636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69017",0.999995193246982,"CDK-mediated phosphorylation and removal of Cdc6",0.999642654907109,0.92160488927828,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.706224996907842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69052",0.999995193246982,"Switching of origins to a post-replicative state",0.999642654907109,0.92160488927828,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.706224996907842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5607764",0.999995193246982,"CLEC7A (Dectin-1) signaling",0.999642654907109,0.977665438308293,0.916648043508376,0.907404860323179,0.897897463723135,0.836131984560791,0.756340021736338,0.718787831778118,0.688303378228243,0.635591139066016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-187577",0.999995193246982,"SCF(Skp2)-mediated degradation of p27/p21",0.999642654907109,0.925506633494393,0.879943791094971,0.967023012148636,0.865794079938095,0.790751893858537,0.706257086214341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5689603",0.999995193246982,"UCH proteinases",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5668541",0.999995193246982,"TNFR2 non-canonical NF-kB pathway",0.999642654907109,0.991507257668133,0.963556769400959,0.967023012148636,0.865794079938095,0.795764756548785,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1280218",0.999995193246982,"Adaptive Immune System",0.999642654907109,0.99702682946141,0.982570072818887,0.989905513157361,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-111885",0.999995193246982,"Opioid Signalling",0.999642654907109,0.96082730795944,0.909247749509794,0.925486703701443,0.792248254824841,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-450531",0.999995193246982,"Regulation of mRNA stability by proteins that bind AU-rich elements",0.999642654907109,0.928965172116894,0.882324535494606,0.877816783476576,0.699965936755003,0.576203072096637,0.497199393992069,0.682913834633565,0.648612394592183,0.596433673788012,0.521883996420851,0.382944717162005,0.372141980164988,0.330166740380124,0.300236718383076,0.282545686441375,0.205745742018806,0.18607802994537,0.18607802994537,0.136464787174491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69563",0.999995193246982,"p53-Dependent G1 DNA Damage Response",0.999642654907109,0.928965172116894,0.882324535494606,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69580",0.999995193246982,"p53-Dependent G1/S DNA damage checkpoint",0.999642654907109,0.928965172116894,0.882324535494606,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8948751",0.999995193246982,"Regulation of PTEN stability and activity",0.999642654907109,0.928965172116894,0.882324535494606,0.967023012148636,0.865794079938095,0.795764756548785,0.714181197422417,0.682913834633565,0.648612394592183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8878166",0.999995193246982,"Transcriptional regulation by RUNX2",0.999642654907109,0.99702682946141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1234174",0.999995193246982,"Cellular response to hypoxia",0.999642654907109,0.932814011888053,0.882324535494606,0.877816783476576,0.699965936755003,0.576203072096637,0.497199393992069,0.682913834633565,0.648612394592183,0.601534080701873,0.526406881792771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-397014",0.999995193246982,"Muscle contraction",0.999642654907109,0.932814011888053,0.882324535494606,0.967023012148636,0.866451391505423,0.797280423459342,0.7164041420648,0.682913834633565,0.648612394592183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-9013694",0.999995193246982,"Signaling by NOTCH4",0.999642654907109,0.938790285187073,0.883913128240566,0.877816783476576,0.699965936755003,0.576203072096637,0.497199393992069,0.682913834633565,0.650977340951355,0.602982690270335,0.530773114509427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-71291",0.999995193246982,"Metabolism of amino acids and derivatives",0.999642654907109,0.99702682946141,0.989488252114266,0.974946573991781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-2871837",0.999995193246982,"FCERI mediated NF-kB activation",0.999642654907109,0.94315675060462,0.891762858828263,0.877816783476576,0.874331939238921,0.806734571174607,0.726741037587003,0.682913834633565,0.650977340951355,0.602982690270335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-6807070",0.999995193246982,"PTEN Regulation",0.999642654907109,0.983070822292096,0.947962285786325,0.974946573991781,0.916740606364936,0.870130558312381,0.79871914789265,0.748125136299766,0.718959164778795,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-163685",0.999995193246982,"Integration of energy metabolism",0.999642654907109,0.981377907989218,0.936778462322142,0.964519412071669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5619115",0.999995193246982,"Disorders of transmembrane transporters",0.999642654907109,0.99702682946141,0.990593327838258,0.974946573991781,0.921251557585068,0.876374379163837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8878159",0.999995193246982,"Transcriptional regulation by RUNX3",0.999642654907109,0.964398741874844,0.9038457857458,0.893976160937466,0.73173118323182,0.59880071228075,0.510443465670531,0.711561191610433,0.680633092329187,0.628435925051977,0.558557384508021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5663205",0.999995193246982,"Infectious disease",0.999642654907109,0.99702682946141,0.990593327838258,0.974946573991781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-202733",0.999995193246982,"Cell surface interactions at the vascular wall",0.999642654907109,0.983070822292096,0.947962285786325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-418594",0.999995193246982,"G alpha (i) signalling events",0.999642654907109,0.983070822292096,0.963556769400959,0.967023012148636,0.865794079938095,0.992333151997691,0.981242712641869,0.953126982687062,0.937613993835078,0.904440013985491,0.87387715613934,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-350562",0.999995193246982,"Regulation of ornithine decarboxylase (ODC)",0.999642654907109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8941858",0.999995193246982,"Regulation of RUNX3 expression and activity",0.999642654907109,0.983070822292096,0.951389026286704,0.967023012148636,0.865794079938095,0.790751893858537,0.704715311577205,0.631014485465288,0.603780541066341,0.539353264922823,0.467977145191732,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-174178",0.999995193246982,"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1",0.999642654907109,0.983070822292096,0.951389026286704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-174184",0.999995193246982,"Cdc20:Phospho-APC/C mediated degradation of Cyclin A",0.999642654907109,0.983070822292096,0.951389026286704,0.967023012148636,0.865794079938095,0.790751893858537,0.705469537515335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-351202",0.999995193246982,"Metabolism of polyamines",0.999642654907109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-68949",0.999995193246982,"Orc1 removal from chromatin",0.999642654907109,0.983070822292096,0.951389026286704,0.967023012148636,0.865794079938095,0.790751893858537,0.705469537515335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69601",0.999995193246982,"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A",0.999642654907109,0.983070822292096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69610",0.999995193246982,"p53-Independent DNA Damage Response",0.999642654907109,0.983070822292096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69613",0.999995193246982,"p53-Independent G1/S DNA damage checkpoint",0.999642654907109,0.983070822292096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-179419",0.999995193246982,"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint",0.999642654907109,0.983070822292096,0.951389026286704,0.967023012148636,0.865794079938095,0.790751893858537,0.706224996907842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-5676590",0.999995193246982,"NIK-->noncanonical NF-kB signaling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-157118",0.999995193246982,"Signaling by NOTCH",0.999642654907109,0.99702682946141,0.963556769400959,0.967023012148636,0.865794079938095,0.749416872098921,0.626386207780916,0.789034151906237,0.761674900060602,0.694381229462457,0.641187882853765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-69002",0.999995193246982,"DNA Replication Pre-Initiation",0.999642654907109,0.983070822292096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-418555",0.999995193246982,"G alpha (s) signalling events",0.999642654907109,0.983070822292096,0.938825114372688,0.974946573991781,0.909631662702211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8939902",0.999995193246982,"Regulation of RUNX2 expression and activity",0.999642654907109,0.985332755967895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-8953854",0.999995193246982,"Metabolism of RNA",0.999642654907109,0.983070822292096,0.94438248536171,0.964519412071669,0.78875098528426,0.655565369593953,0.547209082609005,0.74588709095997,0.716538298549552,0.651690861879102,0.600578407989513,0.458782445557616,0.426342818080286,0.396396586445138,0.361277718674367,0.340698849481145,0.238048156078449,0.198879259623526,0.198879259623526,0.156148826029096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-983705",0.999995193246982,"Signaling by the B Cell Receptor (BCR)",0.999642654907109,0.983070822292096,0.94438248536171,0.974946573991781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-202403",0.999995193246982,"TCR signaling",0.999642654907109,0.983070822292096,0.945820386874736,0.974946573991781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1169091",0.999995193246982,"Activation of NF-kappaB in B cells",0.999642654907109,0.99292528457274,0.963556769400959,0.967023012148636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1236975",0.999995193246982,"Antigen processing-Cross presentation",0.999642654907109,0.99702682946141,0.976825564193488,0.96990615964091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-375276",0.999995193246982,"Peptide ligand-binding receptors",0.999642654907109,0.983070822292096,0.982570072818887,0.96990615964091,0.865794079938095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-1168372",0.999995193246982,"Downstream signaling events of B Cell Receptor (BCR)",0.999642654907109,0.99702682946141,0.978119057454856,0.96990615964091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-3858494",0.999995193246982,"Beta-catenin independent WNT signaling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-416476",0.999995193246982,"G alpha (q) signalling events",0.999642654907109,0.99702682946141,0.990593327838258,0.974946573991781,0.904131825569176,0.974411352294693,0.934723653835463,0.891956247090426,0.86275229822043,0.803635020614006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-202424",0.999995193246982,"Downstream TCR signaling",0.999642654907109,0.99702682946141,0.982570072818887,0.972059206785082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-983169",0.999995193246982,"Class I MHC mediated antigen processing & presentation",0.999642654907109,0.99702682946141,0.982570072818887,0.972059206785082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-382551",0.999995193246982,"Transport of small molecules",0.999642654907109,0.99702682946141,0.999520493740774,0.997615669136272,0.990562786415412,0.990204711153414,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-372790",0.999995193246982,"Signaling by GPCR",0.999642654907109,0.99702682946141,0.990593327838258,0.98940483548894,0.952349709506681,0.998351676746084,0.994057193906065,0.984174580536397,0.973867098063787,0.936827458185127,0.977212555751404,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-373076",0.999995193246982,"Class A/1 (Rhodopsin-like receptors)",0.999642654907109,0.99702682946141,0.989025092203091,0.974946573991781,0.897897463723135,0.983790784523217,0.937909700652423,0.886411860137277,0.848136166258192,0.754646638957151,0.915072692020002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-388396",0.999995193246982,"GPCR downstream signalling",0.999642654907109,0.99702682946141,0.992797153833619,0.98940483548894,0.942998015754216,0.998351676746084,0.994057193906065,0.984174580536397,0.973843745825783,0.933471217345868,0.977212555751404,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"R-HSA-500792",0.999995193246982,"GPCR ligand binding",0.999642654907109,0.99702682946141,0.992513408381924,0.98940483548894,0.937093632973288,0.990204711153414,0.9675962567595,0.922663548413248,0.892595574256574,0.818575566357392,0.94059543514644,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
